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Introduction
The Avon Longitudinal Study of Parents and Children (ALSPAC) 
is a geographically defined, longitudinal birth cohort that 
recruited pregnant women with an estimated date of delivery 
between April 1991 and December 19921,2. During the initial 
recruitment campaign (between 1990 and 1992) women with 
a total of 14,541 pregnancies were enrolled (some women 
had more than one eligible pregnancy during this period). The 
children resulting from these pregnancies and their parents 
have been followed up ever since, primarily via questionnaire, 
hands-on measurement at clinical assessment visits (called 
‘Focus’ clinics) including the provision and assaying of bio-
logical samples and through linkage to routine data. ALSPAC is 
now a three-generational study, comprising ‘G0’: the cohort of 
original pregnant women, the biological father and other 
carers/partners; ‘G1’: the cohort of index children and ‘G2’: the 
cohort of offspring of the index children. The study website 
contains details of all the data that is available through a fully 
searchable data dictionary and variable search tool.
The 2012 G1 cohort profile paper1 describes in detail how the 
families have been followed up until the age of 18 (G1) and 
describes how recruitment was extended to include members 
of families who were eligible to have taken part (using the 
original eligibility criteria), did not initially enrol but who 
subsequently wanted to take part. Families were enrolled into the 
study in phase I between 1990 and 1992 during pregnancy and 
shortly after birth. Further enrolment occurred systematically 
in phase II in 1999 at the age 7 assessment clinic (child mean 
age: 7.5 years) and then opportunistically in phase III from 
1999 until 2012 (child mean age: 17.8 years). Since 2012, 
ALSPAC has conducted an additional systematic recruitment 
drive and have continued to recruit additional families through 
opportunistic contacts and through recruitment of the G2 
offspring of the index children (in phase IV recruitment). This 
data note provides an update on recruitment phases II and III 
and reports specifically on phase IV recruitment: that is, all 
those G1 participants who enrolled in the study from the age of 
18 up to and including the clinic assessment held at age 24 
(mean age 24.5 years). 
Methods
Through the Project to Enhance ALSPAC through Record 
Linkage (PEARL), ALSPAC has retrospectively defined the 
study’s eligible sampling frame through linking study recruitment 
records to NHS delivery records and child health records1. This 
means that the study has a record of the identities (including 
given and family names; date of birth; NHS ID) of most index 
children who are eligible to participate. This has allowed 
ALSPAC to respond to enquiries from both participants and the 
wider public, for example around eligibility to participate and 
use of an individual’s data in research projects. For phase IV 
recruitment, since the age of 18 years, there were three ways in 
which eligible G1 index children (now adults) could enrol into 
ALSPAC. Firstly, all participants who could be traced were 
systematically invited to enrol in a postal exercise conducted 
by PEARL. This was part of their campaign to provide fair 
processing information to G1 as they reached legal adulthood 
and as ALSPAC started to systematically link to their health 
and routine administrative records. Secondly, during recruit-
ment of the G2 participants, the study came into contact with 
individuals - either as the partner of an enrolled participant or 
through screening by midwives – who were eligible but had 
not previously enrolled. Thirdly, eligible participants proactively 
requesting to enrol are always welcomed and enrolled into the 
study.
Study numbers
A total of 20,248 G0 pregnancies (resulting in 20,505 potential 
G1 participants) are eligible to take part in the study. Of 
these pregnancies 116 had an unknown birth outcome. Of the 
eligible pregnancies, the G0 mothers of 14,676 G1 partici-
pants enrolled during the original recruitment campaign (i.e. 
enrolled in phase I). It should be noted that the G0 mothers of 
69 pregnancies with unknown outcome have historically 
always been considered as Phase I enrolees, this is appropriate 
for the G0 cohort profile but not for G1 (since it is not clear 
how many foetuses were in each of these pregnancies and result-
ing offspring have not taken part in the study and therefore 
cannot be adequately quantified). G0 mothers of 456 G1 
participants enrolled during the systematic campaign at age 7 
(i.e. enrolled in phase II). A further 262 G1 participants enrolled 
through opportunistic contact between the ages of 8 and 18 
(i.e. enrolled in phase III). This results in a total of 15,394 
G1 participants who enrolled by the age of 18 (see Figure 1). 
Please note, this is a slight increase since the original cohort 
profile (1) was published.
Since the age of 18, a total of 195 additional G1 participants 
have enrolled (i.e. enrolled in phase IV). Of these, 177 were 
recruited through systematic postal invitations during 2014. 
An additional 14 were recruited through the ALSPAC-G2 
recruitment campaign: This means that an eligible member of 
the cohort enrolled after either: i) becoming pregnant, ii) their 
partner becoming pregnant or iii) they were already a parent. 
Finally, 4 enrolments resulted from ad hoc approaches from 
eligible participants during this period (see Figure 1). As with 
previous phases, phase IV enrolment included two twin 
pregnancies where only one twin enrolled. It should be noted 
that at the time of writing, phase IV participants may not have 
contributed any data to the resource.
A total of 913 (456, 262 and 195 recruited during Phases II, 
III and IV respectively) G1 participants have enrolled who were 
not in the initial study sample (i.e. phase I enrolment). The 
total sample size for analyses is therefore 15,454 pregnancies, 
resulting in 15,589 foetuses. Of this total sample of 15,589 
potential G1 participants, 14,901 were alive at 1 year of age 
(it should be noted that self-reported data are not available 
prior to the time of recruitment for those enrolled in phase II 
or later) and are considered the baseline sample for reporting 
purposes (14,888 excluding triplets and quadruplets – their 
data are not generally released for confidentiality purposes). 
Table 1 summarises the active cases within the study and the 
potential data available at the time of writing.
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Figure 1. The ALSPAC enrolment campaign flow diagram, illustrating enrolment phases I to IV. (adapted from Boyd et al. 20131; Oxford 
University Press, Creative Commons Attribution Non-Commercial License.
Table 1. Activity of G1 (the cohort of index children) and 
illustrative data availability in ALSPAC.
G1 Activity as of February 2019 n
Currently active in study* 13,286
Known address 9,856
Can send Qs 8,964
Can send clinic invites 9,306
Linked to Primary health care data 11,810
Linked to Secondary health care data 12,700
At least one DXA** measure between the ages of 7 and 24 9,144
Genomics data 8,952
Methylation at multiple time points 1,003
G2 parent3 548
DXA - Dual-energy X-ray absorptiometry, G2 - the cohort of offspring of the 
index children
*still alive, not withdrawn, not explicitly opted out
**Body composition assessed using Dual-energy X-ray absorptiometry
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Table 2. Cohort Profile Data File (Version 2b at the time of writing).
Variable name Variable Label
in_alsp Enrolled in ALSPAC
in_core Enrolled as part of original core sample, Phase I
in_phase2 Enrolled as part of phase II, during focus@7
in_phase3 Enrolled as part of phase III, after focus@7 up to age 18
in_phase4 Enrolled as part of phase IV, >=19 & <=24
tripquad Participant is a triplet or quad
kz011b Participant was alive at 1 year of age
kz021 Participant sex
Data availability
ALSPAC data access is through a system of managed open 
access. The steps below highlight how to apply for access to the 
data included in this data note and all other ALSPAC data:
1.    Please read the ALSPAC access policy (http://www.bristol.
ac.uk/media-library/sites/alspac/documents/researchers/
data-access/ALSPAC_Access_Policy.pdf) which describes 
the process of accessing the data and samples in detail, and 
outlines the costs associated with doing so.
2.    You may also find it useful to browse our fully searchable 
research proposals database (https://proposals.epi.bristol.
ac.uk/?q=proposalSummaries), which lists all research 
projects that have been approved since April 2011.
3.    Please submit your research proposal (https://propos-
als.epi.bristol.ac.uk/) for consideration by the ALSPAC 
Executive Committee. You will receive a response within 
10 working days to advise you whether your proposal has 
been approved.
Cohort profile data file
The variables described in the cohort profile data file (ALSPAC 
reference: cp_2b) are provided as a matter of course with all 
data requests (see Table 2). The denominator used in this file 
is the 20,505 G1 eligible sample. The cohort profile data is 
provided in all data extracts, even where participants have 
formally withdrawn from the study or who are at high risk of 
disclosure, though it should be noted in these cases their data 
are supressed.
If you have any questions about the data or how to access it, 
please email alspac-data@bristol.ac.uk.
Consent
Ethical approval for the study was obtained from the ALSPAC 
Ethics and Law Committee and the Local Research Ethics 
Committees. Informed consent for the use of data collected via 
questionnaires and clinics was obtained from participants 
following the recommendations of the ALSPAC Ethics and Law 
Committee at the time. Children were invited to give assent 
where appropriate. Study participants have the right to withdraw 
their consent for elements of the study or from the study entirely 
at any time. Full details of the ALSPAC consent procedures are 
available on the study website (http://www.bristol.ac.uk/alspac/
researchers/research-ethics/).
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